Human natural killer activity: Effects of leukocytic pyrogen/lymphocyte activating factor (LP/LAF), T-cell growth factor (TCGF), and interferon (IFN)
Roy A. Dempsey, David W. Parkinson, Charles A. Dinarello(University of Colorado Anschutz Medical Campus), Lanny J. Rosenwasser(University of Missouri–Kansas City), Mark Allegretta(National Multiple Sclerosis Society), Trevor S. Brown(Pennsylvania State University), J W Mier
Cited by 27
Related Papers
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
|Critical Care Medicine|2015|858
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
|Blood|2008|777
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556
Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel
|Journal of Allergy and Clinical Immunology|2017|502
Common Severe Infections in Chronic Granulomatous Disease
|Clinical Infectious Diseases|2014|426